Last reviewed 2026-04-19 · How we verify

E. Coli Endometritis

Approved treatments

• Claforan · Sterimax
• Pipracil
  Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death.
• Azactam · Bristol-Myers Squibb
  Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent.
• Fortaz · Pai Holdings Pharm
  Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death.
• Mefoxin In Sodium Chloride 0.9% In Plastic Container
• Cefotan
• TICARCILLIN
• Ticarcillin
• Augmentin 250 · Dr Reddys Labs Inc
• Fortaz · Pai Holdings Pharm
  Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance.
• Zosyn · Merck Sharp & Dohme B.V.
  Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively.
• Ceftazidim · Tel-Aviv Sourasky Medical Center

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

• E. Coli Endometritis patent landscape — cliff calendar, originator estates, attackable patents
• E. Coli Endometritis treatment landscape brief
• E. Coli Endometritis treatment updates RSS

Frequently asked questions about E. Coli Endometritis

Related

• Treatment landscape: E. Coli Endometritis patent cliff · E. Coli Endometritis CI report
• Treatment: Claforan · Sterimax
• Treatment: Pipracil
• Treatment: Azactam · Bristol-Myers Squibb
• Treatment: Fortaz · Pai Holdings Pharm
• Treatment: Mefoxin In Sodium Chloride 0.9% In Plastic Container
• All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing